GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESAIY) » Definitions » Additional Paid-In Capital

Eisai Co (Eisai Co) Additional Paid-In Capital : $548 Mil(As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Eisai Co Additional Paid-In Capital?


Eisai Co's quarterly additional paid-in capital declined from Jun. 2023 ($558 Mil) to Sep. 2023 ($533 Mil) but then increased from Sep. 2023 ($533 Mil) to Dec. 2023 ($548 Mil).

Eisai Co's annual additional paid-in capital declined from Mar. 2021 ($714 Mil) to Mar. 2022 ($654 Mil) and declined from Mar. 2022 ($654 Mil) to Mar. 2023 ($590 Mil).

Eisai Co Additional Paid-In Capital Historical Data

The historical data trend for Eisai Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Additional Paid-In Capital Chart

Eisai Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 698.10 720.82 714.16 654.47 589.63

Eisai Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 584.17 589.63 557.72 533.42 547.73

Eisai Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Eisai Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Eisai Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co (Eisai Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESAIY) » Definitions » Additional Paid-In Capital
Comparable Companies
TSE:4507 TSE:4581 TSE:4516 TSE:4530 TSE:4540 TSE:4887 TSE:4506 TSE:4547 TSE:4553 TSE:4521 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA VTRS NBIX XSWX:SDZ SZSE:000538
Traded in Other Exchanges
ESALF:USA 4523:Japan EII:Germany
Address
4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Website
http://www.eisai.co.jp
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.